or
forgot password
  • cancer clinical trials in dallas, TX

  • Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Zale Lipshy University Hospital

    Trial Locations
    Zale Lipshy University Hospital
    University of Texas Southwestern Medical Center
    Saint Paul Hospital
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    MLN8237 in Young Patients With Relapsed or Refractory Solid Tumors or Acute Lymphoblastic Leukemia
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Leukemia, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies
    Mary Crowley Cancer Research Centers
    Dallas, Texas 75201
    Advanced Cancer, Metastatic Cancer, Lymphoma, Solid Tumors, Advanced Malignancies
    Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
    Dallas Surgical Group / Northpoint Cancer Center
    Dallas, Texas 75230
    Breast Cancer, Carcinoma, Lumpectomy, Ductal Carcinoma in Situ
    Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
    Mary Crowley Cancer Research Centers
    Dallas, Texas 75201
    Soft Tissue Sarcoma
    Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
    Zale Lipshy University Hospital
    Dallas, Texas 75235-7786
    Ovarian Stromal Cancer
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Lung Cancer
    Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
    Texas Oncology, P.A.

    Trial Locations
    Texas Oncology, P.A.
    Texas Oncology
    US Oncology Research, Inc.
    Texas Oncology Sammons Cancer Center
    Advanced Breast Cancer
    A Study of IMC-A12 in Islet Cell Cancer
    ImClone Investigational Site
    Dallas, Texas 75230
    Carcinoma, Neuroendocrine Tumors
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
    Baylor University Medical Center
    Dallas, Texas 75246
    Healthy
    A Study of Nilotinib Versus Imatinib in GIST Patients
    University of Texas Southwestern Medical Center DeptofSimmons Cancer Center(3)

    Trial Locations
    University of Texas Southwestern Medical Center DeptofSimmons Cancer Center(3)
    Texas Oncology, P.A. Wichita Falls
    Gastrointestinal Stromal Tumor (GIST)
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    Baylor University Medical Center
    Dallas, Texas 75246
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Parkland Memorial Hospital

    Trial Locations
    Parkland Memorial Hospital
    University of Texas Southwestern Medical Center
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Gemzar, Cisp, Sunitinib Urothelial Ca
    Texas Oncology, P.A.

    Trial Locations
    Texas Oncology, P.A.
    Texas Oncology
    Texas Oncology/Methodist Charlton Cancer Ctr.
    Urothelial Cancer
    BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas

    Trial Locations
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Parkland Memorial Hospital
    Lung Cancer
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
    Baylor Research Institute

    Trial Locations
    Baylor Research Institute
    University of Texas Southwestern Medical Center - Dallas
    Head and Neck Cancer
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    Medical City Dallas-US Oncology

    Trial Locations
    Medical City Dallas-US Oncology
    Texas Oncology, PA/ Methodist Charlton Cancer Center
    Metastatic Pancreatic Cancer
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    Texas Oncology, P.A.

    Trial Locations
    Texas Oncology, P.A.
    Texas Oncology, PA
    US Oncology Research
    Baylor Sammons Cancer Center
    Ovarian Cancer
    A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
    Childrens Medical Center - Univ. of Texas SW Medical Center
    Dallas, Texas 75235
    Neurofibromatosis Type 1
    Stereotactic Body Radiation Therapy and Vertebroplasty in Treating Patients With Localized Spinal Metastasis
    University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    Center For Oncology Research & Treatment, P.A.
    Dallas, Texas 75230
    Prostate Cancer
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    Medical City Dallas Hospital
    Dallas, Texas 75230
    Lung Cancer
    Sunitinib Non Small Cell Lung Cancer Patients Over 70
    Methodist Charlton Cancer Ctr.
    Dallas, Texas 75237
    Non Small Cell Lung Cancer
    A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma
    Baylor Sammons Cancer Center / Texas Oncology
    Dallas, Texas 75246
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
    Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung Tumors
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Lung Cancer
    Strategic Timing of Antiretroviral Treatment
    UT Southwestern Clinical Research Unit
    Dallas, Texas 75235
    HIV Infection
    Pioglitazone as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Treatment With Gemcitabine
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Dallas, Texas 75390
    Pancreatic Cancer
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Medical City Dallas Hospital

    Trial Locations
    Medical City Dallas Hospital
    Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
    Leukemia, Lymphoma
    A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer
    Texas Oncology, PA

    Trial Locations
    Texas Oncology, PA
    Texas Cancer Center at Medical City
    Breast Cancer